Category Internal Medicine

Enoximone

See also Phosphodiesterase type III inhibitors General information Enoximone is an inhibitor of phosphodiesterase type III, and has a positive inotropic effect. Its most common adverse effects are gastrointestinal and cardiac. The gastrointestinal effects include anorexia, nausea, vomiting, and diarrhea…

Enfuvirtide

General information Enfuvirtide is a 36 amino acid synthetic peptide used for managing HIV treatment-experienced patients. It is a fusion inhibitor that binds to HR 1, blocking a conformational change on gp41 required for the fusion of the lipid envelope…

Enflurane

General information Enflurane is a non-explosive halogenated volatile anesthetic that was first marketed in 1966. It was developed in the search for agents safer than halothane and methoxyflurane [ ]. However, the list of its halothane-like adverse effects has continued…

Encainide

General information Encainide is a class I antidysrhythmic drug. Reviews of its clinical pharmacology, clinical use, efficacy, and adverse effects have appeared [ ]. Organs and systems Cardiovascular In the wake of the preliminary and final reports of the Cardiac…

Enalapril

See also Angiotensin-converting enzyme inhibitors General information Enalapril is an ACE inhibitor used in the treatment of hypertension and heart failure and prophylactically in patients with asymptomatic left ventricular dysfunction. Organs and systems Cardiovascular Of all studies of the effects…

Enadoline

General information Enadoline is an opioid agonist at KOR (OP2, κ) receptors and has no effects attributable to MOR (OP3, μ) receptor actions, such as respiratory depression. However, enadoline does not offer any benefits over other currently available opioids. In…

Emtricitabine

See also Non-nucleoside reverse transcriptase inhibitors (NNRTIs) General information Emtricitabine is nucleoside reverse transcriptase inhibitor (NRTI) used in the treatment of HIV General adverse effects and adverse reactions The most common adverse events during the use of regimens containing emtricitabine…